Surgery Historical Balance Sheet
SGRY Stock | USD 24.19 0.20 0.82% |
Trend analysis of Surgery Partners balance sheet accounts such as Total Current Liabilities of 397.5 M, Total Stockholder Equity of 1.9 B, Other Liabilities of 38.2 M or Property Plant And Equipment Net of 715.2 M provides information on Surgery Partners' total assets, liabilities, and equity, which is the actual value of Surgery Partners to its prevalent stockholders. By breaking down trends over time using Surgery Partners balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Surgery Partners latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgery Partners is a good buy for the upcoming year.
Surgery Partners Inventory |
|
Surgery |
About Surgery Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Surgery Partners at a specified time, usually calculated after every quarter, six months, or one year. Surgery Partners Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Surgery Partners and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Surgery currently owns. An asset can also be divided into two categories, current and non-current.
Surgery Partners Balance Sheet Chart
Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Surgery Partners assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Surgery Partners books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most accounts from Surgery Partners' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2.6 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 66.1 M in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 2.9B | 3.1B | 393.5M | 373.8M | Total Assets | 6.7B | 6.9B | 7.9B | 5.0B |
Surgery Partners balance sheet Correlations
Click cells to compare fundamentals
Surgery Partners Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgery Partners balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Common Stock Shares Outstanding | 48.8M | 72.4M | 92.0M | 125.6M | 126.1M | 66.1M | |
Total Assets | 5.4B | 6.1B | 6.7B | 6.9B | 7.9B | 5.0B | |
Short Long Term Debt Total | 3.2B | 3.3B | 2.9B | 3.1B | 393.5M | 373.8M | |
Other Current Liab | 353M | 247.0M | 242.5M | 240.3M | 314.3M | 261.0M | |
Total Current Liabilities | 556.8M | 536.8M | 493.4M | 523M | 624.4M | 397.5M | |
Total Stockholder Equity | 115.6M | 1.1B | 2.0B | 2.0B | 1.8B | 1.9B | |
Other Liab | 62.9M | 440.6M | 402.6M | 35M | 40.3M | 38.2M | |
Property Plant And Equipment Net | 854.7M | 953.8M | 1.2B | 1.2B | 1.4B | 715.2M | |
Net Debt | 2.9B | 2.9B | 2.6B | 2.9B | 124M | 117.8M | |
Retained Earnings | (431.8M) | (502.7M) | (557.3M) | (569.2M) | (737.3M) | (700.4M) | |
Accounts Payable | 100.2M | 124.9M | 151.6M | 171.8M | 208.7M | 108.0M | |
Cash | 317.9M | 389.9M | 282.9M | 195.9M | 269.5M | 194.7M | |
Non Current Assets Total | 4.6B | 5.2B | 5.8B | 6.0B | 6.8B | 4.3B | |
Non Currrent Assets Other | 27M | 59.1M | 144.2M | 103.3M | 57.5M | 52.7M | |
Other Assets | 129.5M | 554M | 5.2B | 122.3M | 140.6M | 133.6M | |
Long Term Debt | 2.8B | 2.9B | 2.6B | 2.7B | 3.3B | 2.3B | |
Cash And Short Term Investments | 317.9M | 389.9M | 282.9M | 195.9M | 269.5M | 194.7M | |
Net Receivables | 382.2M | 430.2M | 456.3M | 496.4M | 579.1M | 357.4M | |
Good Will | 3.5B | 3.9B | 4.1B | 4.3B | 5.1B | 3.3B | |
Liabilities And Stockholders Equity | 5.4B | 6.1B | 6.7B | 6.9B | 7.9B | 5.0B | |
Non Current Liabilities Total | 3.2B | 3.3B | 2.9B | 3.0B | 5.5B | 2.9B | |
Inventory | 56.4M | 61.1M | 71.4M | 75.2M | 88.4M | 52.2M | |
Other Current Assets | 45M | 64.9M | 110.4M | 127.5M | 182.4M | 95.9M | |
Other Stockholder Equity | 607.9M | 1.6B | 2.5B | 2.5B | 2.5B | 2.6B | |
Total Liab | 5.4B | 6.1B | 6.7B | 3.5B | 4.3B | 4.3B | |
Property Plant And Equipment Gross | 854.7M | 1.2B | 1.5B | 1.7B | 1.9B | 2.0B | |
Total Current Assets | 801.5M | 946.1M | 921M | 895M | 1.1B | 676.9M | |
Accumulated Other Comprehensive Income | (61M) | (31.5M) | 76.2M | 57.5M | 4.8M | 5.0M | |
Short Term Debt | 103.6M | 100.5M | 99.3M | 110.9M | 101.4M | 74.2M | |
Intangible Assets | 46.9M | 43.7M | 42.3M | 54.8M | 45.7M | 52.9M | |
Property Plant Equipment | 821M | 854.7M | 953.8M | 1.2B | 1.3B | 1.4B | |
Net Tangible Assets | (3.2B) | (2.4B) | 1.1B | (1.6B) | (1.8B) | (1.9B) | |
Current Deferred Revenue | 109.8M | 64.4M | 3.2M | 108.5M | 124.8M | 131.0M | |
Long Term Investments | 90.3M | 88.7M | 190.3M | 184.1M | 215.4M | 111.7M | |
Short Long Term Debt | 64.4M | 60.4M | 62.8M | 73.3M | 101.4M | 61.0M | |
Warrants | 1.1B | 741.3M | 330.2M | 342M | 393.3M | 673.0M | |
Noncontrolling Interest In Consolidated Entity | 686.6M | 766.5M | 880.6M | 942.7M | 1.1B | 724.6M | |
Common Stock Total Equity | 395.5M | 435M | 900K | 1.3M | 1.5M | 1.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.